FORUM HR - PEOPLE & CULTURE 2025
Forum HR – People & Culture 2025,
Now in its 19th edition, the Forum evolves from a national event into a European platform on the new culture of work, connecting people, companies, and innovation.
Co-Intelligence: The New Culture of Work
2025 theme – "Co-Intelligence" – represents the meeting point between human and artificial intelligence, between technological efficiency and human value.
It marks a paradigm shift: from managing resources to empowering people, from individual performance to collective intelligence.
The Forum will bring together over 3,000 participants and more than 350 speakers – including HR Directors, CEOs, academics, and innovation leaders – through talk shows, keynotes, workshops, and executive roundtables exploring how technology, culture, and sustainability are reshaping work in
International Expansion and f ree Registration
For the first time, the Forum will feature an International HUB with English-language sessions led by C-level HR speakers from across
This initiative aims to promote a cross-border dialogue on innovation, leadership, and sustainable work culture.
Free registration for international participants is available here:
Registration Form
"By opening the Forum to the international HR community,
About Comunicazione Italiana
Comunicazione Italiana is
It connects over 240,000 professionals through events and projects promoting innovation, sustainability, and human-centered leadership.
Press Office:-
Giovanni Sacchitelli,
[email protected]
Photo: https://mma.prnewswire.com/media/2803642/Event_Banner.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/forum-hr--people--culture-2025-302592661.html
SOURCE Comunicazione Italiana
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth
- DMG Blockchain Solutions Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call Details
- Akeso's AK157D1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share